Athena Investment Management
Source: SEC Form 13F · as of Mar 2026Athena Investment Management holds 12 biotech & pharma companies tracked by BioSniper, totaling $13.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$13.2M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 11,340 | $2.5M |
| JNJJOHNSON & JOHNSON | 8,180 | $2.0M |
| PFEPFIZER INC | 52,302 | $1.5M |
| AMGNAMGEN INC | 3,883 | $1.4M |
| LLYELI LILLY & Co | 1,281 | $1.2M |
| ABTABBOTT LABORATORIES | 10,497 | $1.1M |
| MRKMerck & Co., Inc. | 8,777 | $1.1M |
| VTRSViatris Inc | 72,134 | $975K |
| BMYBRISTOL MYERS SQUIBB CO | 15,115 | $917K |
| GILDGILEAD SCIENCES, INC. | 1,749 | $244K |
| CAHCardinal Health Inc. | 1,025 | $217K |
| GEHCGE HealthCare Technologies Inc. | 3,019 | $215K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.